Supplement To Earnings News Release - 2Q2014

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2014.
       
Second Quarter   Second Quarter
$ in millions, except EPS amounts   2014   2013
Sales   $10,934   $11,010
GAAP EPS   0.68   0.30

Non-GAAP EPS that excludes items listed below 1
  0.85   0.84

GAAP Net Income 2
  2,004   906
Non-GAAP Net Income that excludes items listed below 1,2   2,493   2,530
 

Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.85 exclude acquisition- and divestiture-related costs, restructuring costs and certain other items.

If you liked this article you might like

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Why You Keep Cash on Hand; No Downside Conviction -- Jim Cramer's Top Thoughts